Uncategorized

Uncategorized

New Releases from NCBI BookshelfOlopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Ryaltris): Indication: For the symptomatic treatment of moderate to severe seasonal allergic rhinitis and associated ocular symptoms in adults, adolescents, and children aged 6 years and older: Reimbursement Recommendation [Internet].​Olopatadine Hydrochloride and Mometasone Furoate Nasal Spray (Ryaltris): Indication: For the symptomatic treatment of moderate to severe seasonal allergic rhinitis and associated ocular symptoms in adults, adolescents, and children aged 6 years and older: Reimbursement Recommendation [Internet].

Canada’s Drug Agency (CDA-AMC) recommends that Ryaltris should not be reimbursed by public drug plans for the symptomatic treatment of

Uncategorized

New Releases from NCBI BookshelfManagement of Anemia and/or Bleeding in Patients Who Will Not Accept Blood Products: Guideline Overview, Purpose, and Scope [Internet].​Management of Anemia and/or Bleeding in Patients Who Will Not Accept Blood Products: Guideline Overview, Purpose, and Scope [Internet].

Objective is to provide recommendations regarding patients that will not accept blood transfusions and have symptomatic or severe anemia (with

Scroll to Top